Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ODI Pharma ABXSAT:ODI +3.25%46 Pretax Margin % is 1.00% as of Mar. 2026. GuruFocus rates XSAT:ODI with a GF Score™ of 46/100 and a GF Value™ of kr9.52 (Significantly Undervalued). Among 961 Drug Manufacturers companies, ODI Pharma AB ranks worse than 67.95% on this metric.
Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. ODI Pharma AB's Pre-Tax Income for the
three
months ended in Mar. 2026 was kr0.13 Mil. ODI Pharma AB's Revenue for the
three
months ended in Mar. 2026 was kr12.71 Mil. Therefore, ODI Pharma AB's pretax margin for the quarter that ended in Mar. 2026 was 1.00%.
The historical rank and industry rank for ODI Pharma AB's Pretax Margin % or its related term are showing as below:
XSAT:ODI'
s Pretax Margin % Range Over the Past 10 Years
Min: -4960.43 Med: -1250.5 Max: -0.92
Current: -0.92
XSAT:ODI's Pretax Margin % is ranked worse than 67.95% of 961
companies
in the Drug Manufacturers industry
Industry Median: 7.28
vs XSAT:ODI: -0.92
ODI Pharma AB (XSAT:ODI) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
ODI Pharma AB Pretax Margin % Related Terms
ODI Pharma AB Pretax Margin % Historical Data
* Premium members only.
The historical data trend for ODI Pharma AB's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSAT:ODI vs ZTS, UTHR, VTRS: Pretax Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, ODI Pharma AB's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ODI Pharma AB Pretax Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, ODI Pharma AB's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where ODI Pharma AB's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ODI Pharma AB (XSAT:ODI) has a Pretax Margin % of 1.00% as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on ODI Pharma AB and its competitors. According to the industry distribution chart, ODI Pharma AB ranks #653 out of 961 companies in the Drug Manufacturers industry, placing it in the top 68%.
Is ODI Pharma AB's Pretax Margin % too high?
ODI Pharma AB's current Pretax Margin % is 1.00%. The Drug Manufacturers industry median Pretax Margin % is 7.28. ODI Pharma AB's value of 1.00% is 86.3% below this industry median. Based on the distribution chart, ODI Pharma AB ranks #653 out of 961 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, ODI Pharma AB has a GF Score™ of 46/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does ODI Pharma AB's Pretax Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, ODI Pharma AB ranks #653 out of 961 companies for Pretax Margin %. This places ODI Pharma AB in the lower half of its industry. The industry median Pretax Margin % is 7.28. ODI Pharma AB's value of 1.00% is 86.3% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Drug Manufacturers company?
The median Pretax Margin % among Drug Manufacturers companies is 7.28, based on 961 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. ODI Pharma AB's current Pretax Margin % of 1.00% is 86.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on ODI Pharma AB and its competitors. For the Drug Manufacturers industry, the median Pretax Margin % is 7.28 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ODI Pharma AB's current Pretax Margin % is 1.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ODI Pharma AB stock overvalued right now?
Based on GuruFocus' analysis, ODI Pharma AB (XSAT:ODI) is currently considered Significantly Undervalued. The stock's GF Value™ is kr9.52, compared to a current price of kr2.54 — trading 73.3% below its estimated fair value. The current Pretax Margin % is 1.00% and 86.3% below the Drug Manufacturers industry median of 7.28. ODI Pharma AB's overall GF Score™ is 46/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For ODI Pharma AB (XSAT:ODI), the current Pretax Margin % is 1.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is ODI Pharma AB (XSAT:ODI) Overvalued in 2026?
Based on GuruFocus' analysis, ODI Pharma AB stock appears to be undervalued.
The current stock price of kr2.54 is trading 73.3% below its estimated GF Value™ of kr9.52.
GuruFocus considers ODI Pharma AB to be Significantly Undervalued.
Key valuation signals for XSAT:ODI:
Pretax Margin %: 1.00%
GF Value™: kr9.52 vs. price of kr2.54 (73.3% below fair value)
Industry Position: 86.3% below the Drug Manufacturers median (#653 of 961)
No single metric tells the full story. See the XSAT:ODI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSAT:ODI has been successfully added to your 
